medline.ch Respirationstrakt Neoplasie

	Triangulating Evidence on Serum Uric Acid and Cancer Risk: Consistent Inverse Associations With Lung Cancer. Cancer Sci Matsunaga T, Wakai K, Tamura T, Nagayoshi M, Okada R, Kageyama I, Hara M, Furukawa T, Ikezaki H, Matsumoto Y, Nishiyama T, Nakagawa-Senda H, Koriyama C, Tanoue S, Takashima N, Ozaki E, Miura K, Kadota A, Watanabe T, Ishizu M, Kuriki K, Nakatochi M, Momozawa Y, Imoto I, Oze I, Matsuo K, J. PMID: 42764192 [PubMed - as supplied by publisher]
	Sovereignty and Survival: Understanding Lung Cancer Outcomes for Aboriginal and Torres Strait Islander People in Australia, a Case-Control Study. Med J Aust Bergin ART, Te Marvelde L, Milne RL, Solomon BJ, Ivanova K, Savas P, Luen SJ, Hamann J, Casey A, Watt N, Evans SM, Garvey G, Loi S. PMID: 42764147 [PubMed - indexed for MEDLINE]
	Prophylactic cranial irradiation versus active MRI surveillance for limited-stage small-cell lung cancer achieving response after chemoradiotherapy: a protocol for a randomized, controlled, multicenter, phase III trial. Respir Res Wei Z, Chen Y, Yu J, Meng X. PMID: 42763407 [PubMed - indexed for MEDLINE]
	Efficacy and safety of omitting the clinical target volume in limited-stage small cell lung cancer: a large-scale multicenter real-world study. Radiother Oncol Wang X, Yu X, Liu X, Zhao K, Li Y, Feng H, Sun M, Yu J, Chen Y, Meng X. PMID: 42763051 [PubMed - as supplied by publisher]
	Tarlatamab in small cell lung cancer following platinum-based chemotherapy: subgroup analysis of Japanese patients from the DeLLphi-304 study. Int J Clin Oncol Kurata T, Sugawara S, Akamatsu H, Wakuda K, Azuma K, Takahama T, Kagamu H, Yokouchi H, Satouchi M, Murakami S, Ohashi K, Nishio M, Nishino K, Izumi H, Tanaka H, Miyawaki T, Huang S, Patil U, Park J, Yoshida T. PMID: 42762420 [PubMed - as supplied by publisher]
	Artificial Intelligence-Assisted Pulmonary Nodule Diagnosis by Thoracic Surgeons: A Comparative Study on Clinical Effectiveness. Thorac Cancer Jeon YJ, Jeong J, Park D, Kang JH, Hong EK, Chung Y, Park B, Park SY. PMID: 42762092 [PubMed - indexed for MEDLINE]
	Development of a Nursing Quality Evaluation Indicator System for Lung Cancer in Traditional Chinese Medicine Based on the Donabedian Model: A Delphi Study. J Multidiscip Healthc Duan T, Liu Y, Wang H. PMID: 42761912 [PubMed]
	Lineage plasticity and immune invisibility in primary SCLC and LUAD-to-SCLC transformation: antigen presentation loss and therapeutic redirection. Front Immunol Xu H, Li B, Yang J, Tang X. PMID: 42761714 [PubMed - indexed for MEDLINE]
	Precision Multimodal Nanodynamic Therapy for Lung Cancer: From Tumor Microenvironment-Responsive Platforms to Cell-Death Reprogramming and Immune Remodeling. Int J Nanomedicine Gou K, Zhang Z, Yi S, Zhu X, Zhou F, Zhou J, Xu T, Huang N. PMID: 42761669 [PubMed - indexed for MEDLINE]
	Construction and verification of a nomogram to predict the probability of venous thromboembolism in lung cancer patients. Front Mol Biosci Deng R, Wu J, Tang F, Li Y, Zhong Q, Tong Y, Ni T, Zhang Y. PMID: 42761046 [PubMed]
	Case Report: Neuroendocrine-low POU2F3-positive small cell lung cancer presenting as a diagnostically unstable thoracic malignancy. Front Oncol Ma Y, Chen W, Guo F, Han S. PMID: 42760987 [PubMed]
	Rechallenge With Immunotherapy for ES-SCLC: Efficacy and Safety From a Retrospective Propensity Score-Matched Study. Cancer Med Wang Y, Tong Y, Pan Y, Li X, Li H. PMID: 42760803 [PubMed - indexed for MEDLINE]
	Effect of esketamine on postoperative pulmonary complications after radical surgery for lung cancer: A randomized double-blind controlled trial. Medicine (Baltimore) Huang J, Wang J, Gu X, Pang P, Zhang L. PMID: 42760676 [PubMed - indexed for MEDLINE]
	Primary laryngeal paraganglioma with multisystem metastases: A case report. Medicine (Baltimore) Xu X, Ma S, Zou Y. PMID: 42760654 [PubMed - indexed for MEDLINE]
	CT-based deep foundation model for predicting immune checkpoint inhibitor-induced pneumonitis risk in lung cancer. J Immunother Cancer Muneer A, Showkatian E, Kitsel Y, Saad MB, Sujit SJ, Soto F, Shroff GS, Faiz SA, Ghanbar MI, Ismail SM, Vokes NI, Cascone T, Le X, Zhang J, Byers LA, Jaffray D, Chang JY, Liao Z, Naing A, Gibbons DL, Vaporciyan AA, Heymach JV, Suresh K, Altan M, Sheshadri A, Wu J. PMID: 42759982 [PubMed - indexed for MEDLINE]
	Reduced invasiveness of lobe-specific lymph node dissection in lung cancer surgery: Propensity score matching analysis using Japanese real-world data. J Thorac Cardiovasc Surg Adachi H, Yamamoto H, Yamamoto K, Ito H, Saito A, Shimada Y, Chen-Yoshikawa TF, Sato Y, Okada M, Yoshino I. PMID: 42759767 [PubMed - as supplied by publisher]
	Lung Cancer Screening Uptake Among Adults Newly Eligible Under the 2023 American Cancer Society Guideline Compared With USPSTF-Eligible Adults: A Nationwide Cross-Sectional Study. Chest Jia Y, Zhao J, Rivera MP. PMID: 42759647 [PubMed - as supplied by publisher]
	Impact of intensity, duration and type of acute and chronic exercise on the immune response in lung cancer - application of the FITTT-principle. Crit Rev Oncol Hematol Spielbüchler L, Taucher E, Deniz EB, Birnbaumer P, Kneidinger N, Hofmann P. PMID: 42759583 [PubMed - as supplied by publisher]
	A two-gene prognostic model for lung adenocarcinoma using summary-data-based Mendelian randomization analysis and Cox proportional hazards regression. Future Sci OA Xu J, Liu X, Lu Z, Wu X, Yu X, Wang S. PMID: 42758874 [PubMed]
	Automated three-dimensional radiomic body composition analysis enhances survival prediction in resectable nonâ€‘small cell lung cancer. Eur Radiol Exp Huang Y, Li C, Yang F, Chen X, Chen X, Huang Y, Zhang Z, Yang L, Jiang Y, Cun H, Mou Z, Yang W, Liu Z, He B. PMID: 42758420 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 163187

Seite 1 von 8160



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung